This article was taken from: https://www.bbc.co.uk/news/health-50577728 By BBC Health News A major trial of an immunotherapy drug has shown it can be effective in some men with advanced prostate cancer. The men had stopped responding to the main treatment options. Researchers found that a small proportion of men, described as “super responders”, remained well even…
This article was taken from: https://www.bbc.co.uk/news/health-50516536 By BBC Health news More than one in 10 cancer patients die from heart and blood vessel problems, rather than their initial illness, a study says. The European Heart Journal looked at three million US patients, with 28 different cancers, over 40 years. The researchers say the increase in…
This article was taken from: https://www.telegraph.co.uk/science/2019/09/30/revolution-prostate-cancer-care-off-label-breast-cancer-drug/ By Henry Bodkin, health correspondent Abreast cancer drug has been used to double the survival of men with advanced prostate cancer, becoming the first successful precision medicine for the disease. Doctors at the Royal Marsden Hospital who conducted the trial say the results amount to a “revolution” in prostate cancer care. They…
This article was taken from: https://www.bbc.co.uk/news/health-49877843 By BBC Health news Olaparib could become a revolutionary treatment for prostate cancer – the first genetically targeted drug for fighting the disease, say experts. The precision medicine is already used by the NHS for ovarian cancer and has been called a game-changer by cancer doctors. A cancer conference heard how,…
This article was taken from: http://www.nationalhealthexecutive.com/The-Scalpels-Daily-Blog/urology-nurses-are-leading-the-way-in-adoption-of-prostate-cancer-biopsy-technique By Jonah Rusere What is TRexit and why is it great news for prostate cancer patients all over the country? Let me explain. TRexit is the name given to a national initiative for hospitals to phase out TRUS biopsies and replace them with transperineal biopsies under local anaesthetic (LA…